BIOACTIVATION OF DIETARY PHENOLS BY HEMOPROTEINS
血蛋白对膳食酚类的生物活性
基本信息
- 批准号:6137434
- 负责人:
- 金额:$ 21.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 2002-12-31
- 项目状态:已结题
- 来源:
- 关键词:DNA damage animal genetic material tag butylated hydroxytoluene carcinogen testing chemical carcinogenesis cytochrome P450 dietary constituent drug metabolism enzyme activity enzyme induction /repression enzyme inhibitors glutathione transferase laboratory mouse lung neoplasms metallothionein mutagen testing mutagens neoplasm /cancer genetics nutrition related tag quinones tissue /cell culture tumor promoters
项目摘要
The long-term goal of this research is to elucidate the underlying
mechanisms by which phenolic compounds present in the human diet influence
tumorigenesis. Ongoing studies demonstrates that the oxidative metabolism
of alkylphenols by cytochromes P450 lead, in many cases, to the formation
of quinoid products capable of covalent binding and/or free radical
generation in cells. We now propose to extend this work to investigate the
involvement of such reactive metabolites in tumor promotion utilizing the
most thoroughly characterized model for probing mechanistic aspects of
promotion in the lung. This system involves the enhancement of lung tumor
development by chronic administration of the food additive butylated
hydroxytoluene (BHT) to carcinogen-initiated mice. It has been
demonstrated that metabolism of BHT in the target organ is necessary for
promotion and it is known that BHT is converted to reactive quinoid
metabolites in lung. These findings lead to the hypothesis that promotion
depends upon two successive P450 catalyzed oxidations to the ultimate
promoting species, a strongly electrophilic quione methide which alkylates
one or more critical proteins leading to a disruption of growth control
mechanisms. The following specific aims are proposed: (1) Determine the
role of metabolism in the differential responsiveness of promotion-
sensitive (B+) and promotion-resistant (B-) mice to the lung tumor
promoter BHT. Conversion of BHT to a quinone methide and other reactive
metabolites, as well as the detoxification of reactive metabolites, will
be examined in lung tissues and cells from B+ and B- mice. (2) Investigate
alkylation targets of a BHT-derived quinone methide in lung cells that
directly or indirectly impair cell-cell signaling. Protein alkylation by
a highly reactive quinone methide metabolite of BHT will be examined in
cells isolated from the lungs of B= and B- mice, and in tumorigenic and
non-tumorigenic cell lines derived from murine lung. Alkylation patterns
will be compared by radiochemical and immunochemical methods and selected
adducts identified by mass spectrometry and microsequencing. (3) Examine
biochemical consequences and oxidative damage in lung cells exposed to
reactive metabolites of BHT. Isolated cells from B+ and B- mice and cell
lines will be treated with reactive quinoid metabolites of BHT to
investigate cytotoxicity, oxidative damage, inhibition of mitochondrial
function, and inhibition of enzymes involved in detoxification.
这项研究的长期目标是阐明
人类饮食中存在的酚类化合物影响
肿瘤发生正在进行的研究表明,
在许多情况下,细胞色素P450导致烷基酚的形成,
能够共价结合和/或自由基
在细胞中生成。我们现在建议将这项工作扩展到调查
这些反应性代谢物参与肿瘤促进,
最彻底的特征模型,用于探索
在肺中提升。该系统涉及肺肿瘤的增强
通过长期服用食品添加剂丁基化
羟基甲苯(BHT)致癌物启动的小鼠。已经
证明了BHT在靶器官中的代谢对于
促进,并且已知BHT转化为反应性醌型化合物
肺中的代谢物。这些发现引出了一个假设,
取决于两个连续的P450催化氧化,
促进物种,一种强亲电醌甲基化物,
一种或多种导致生长控制中断的关键蛋白质
机制等具体目标如下:(1)确定
代谢在促进的不同反应中的作用-
对肺肿瘤敏感(B+)和促进耐药(B-)小鼠
促进剂BHT。BHT转化为醌甲基化物和其他反应性
代谢物,以及反应性代谢物的解毒,将
在来自B+和B-小鼠的肺组织和细胞中进行检查。(2)探讨
BHT衍生的醌甲基化物在肺细胞中的烷基化靶点,
直接或间接损害细胞间信号传导。蛋白质烷基化,
BHT的高反应性醌甲基化物代谢产物将在
从B=和B-小鼠的肺中分离的细胞,以及在致瘤性和
来源于鼠肺的非致瘤细胞系。烷基化模式
将通过放射化学和免疫化学方法进行比较,
通过质谱和微测序鉴定加合物。(3)审查
肺细胞的生化后果和氧化损伤
BHT的反应性代谢产物。从B+和B-小鼠中分离细胞,
将用BHT的反应性醌型代谢物处理细胞系,
研究细胞毒性、氧化损伤、线粒体抑制
功能和抑制解毒酶。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN A THOMPSON其他文献
JOHN A THOMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN A THOMPSON', 18)}}的其他基金
A PHASE I EVALUATION OF THE SAFETY AND PK OF PRO-1 IN STAGE IV MELANOMA PATIENTS
PRO-1 在 IV 期黑色素瘤患者中的安全性和 PK 的 I 期评估
- 批准号:
7379363 - 财政年份:2006
- 资助金额:
$ 21.16万 - 项目类别:
A PHASE I STUDY TO EVALUATE THE SAFETY AND PK OF PRO-1 IN STAGE IV PATIENTS
评估 PRO-1 在 IV 期患者中的安全性和 PK 的 I 期研究
- 批准号:
7198874 - 财政年份:2005
- 资助金额:
$ 21.16万 - 项目类别:
Allo Stem Cell Transplant as Immunotherapy for Melanoma
同种异体干细胞移植作为黑色素瘤的免疫疗法
- 批准号:
6446455 - 财政年份:2001
- 资助金额:
$ 21.16万 - 项目类别:
Allo Stem Cell Transplant as Immunotherapy for Melanoma
同种异体干细胞移植作为黑色素瘤的免疫疗法
- 批准号:
6522680 - 财政年份:2001
- 资助金额:
$ 21.16万 - 项目类别:
ACQUISTION OF AN ELECTROSPRAY TANDEM MASS SPECTROMETER
购买电喷雾串联质谱仪
- 批准号:
2503084 - 财政年份:1998
- 资助金额:
$ 21.16万 - 项目类别:
PRECLINICAL MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION
慢性同种异体肾移植排斥的临床前模型
- 批准号:
2017362 - 财政年份:1997
- 资助金额:
$ 21.16万 - 项目类别:
PRECLINICAL MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION
慢性同种异体肾移植排斥的临床前模型
- 批准号:
2713441 - 财政年份:1997
- 资助金额:
$ 21.16万 - 项目类别:
FORMATION AND REACTIVITY OF TOXIC QUINONE METHIDES
有毒醌甲基化物的形成和反应性
- 批准号:
2155070 - 财政年份:1994
- 资助金额:
$ 21.16万 - 项目类别:
Bioactivation of Dietary Phenols by Hemoproteins
血红素蛋白对膳食酚类的生物活化
- 批准号:
6785870 - 财政年份:1994
- 资助金额:
$ 21.16万 - 项目类别:
BIOACTIVATION OF DIETARY PHENOLS BY HEMOPROTEINS
血蛋白对膳食酚类的生物活性
- 批准号:
6341884 - 财政年份:1994
- 资助金额:
$ 21.16万 - 项目类别:














{{item.name}}会员




